Evaluation of intrathecal dexamethasone and sufentanil in natural vaginal delivery

Evaluation of analgesia duration and delivery outcomes following dexamethasone addition to intrathecal sufentanil in natural vaginal delivery

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220419054587N1

Enrollment

Registered

2022-06-14

Start date

2022-06-23

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labour pain. Encounter for full-term uncomplicated delivery

Interventions

Intervention 1: Intervention group: Spinal anesthesia is performed by intrathcal injection of 5 g of sufentanil as a single shot with 8 mg of intrathecal dexamethasone, the period from which the mothe

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age between 20-35 year

Exclusion criteria

Exclusion criteria: Multiples Underlying disease Drug history

Design outcomes

Primary

Measure	Time frame
Duration of analgesia. Timepoint: From intervention to the end of labor. Method of measurement: The first request for repeated analgesia by the mother.;Labour phase. Timepoint: From intervention to the end of labour. Method of measurement: Serial examination to check the course of labour.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaede Masoumzadeh

Karaj University of Medical Sciences

Maede.masoumzadeh@gmail.com+98 919 263 2208

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026